19 related articles for article (PubMed ID: 1871090)
1. Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model.
Valiulin SV; Onischuk AA; Baklanov AM; Dubtsov SN; Dultseva GG; An'kov SV; Tolstikova TG; Belogorodtsev SN; Schwartz YS
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358182
[TBL] [Abstract][Full Text] [Related]
2. [BCG vaccination and increasing the effectiveness of treatment of post-vaccination complications by the use of rifampicin and dimexide].
Mitinskaia LA; Iukhimenko NV; Kamaeva VF
Probl Tuberk; 1994; (5):4-7. PubMed ID: 7870725
[TBL] [Abstract][Full Text] [Related]
3. [Dimexide in the treatment of endobronchitis in patients with destructive forms of pulmonary tuberculosis].
Liubinets VI; Kruk MV
Zh Ushn Nos Gorl Bolezn; 1969; 29(6):68-71. PubMed ID: 5376129
[No Abstract] [Full Text] [Related]
4. Rifampicin in the treatment of resistant pulmonary tuberculosis.
Wäre M; Lorenzen J
Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
[No Abstract] [Full Text] [Related]
5. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
6. [Effect of dimethyl sulfoxide (dimexide) on the blood bacteriostatic activity of children with pulmonary tuberculosis].
Lebedeva LV; Nikolaeva NV; Gur'ian IE; Karavatskaia VP
Pediatriia; 1980; (9):24-5. PubMed ID: 6968885
[No Abstract] [Full Text] [Related]
7. [Therapeutic possibilities of inhalation of rifampicin with dimexide in phthisiopulmonology].
Gorbach IN; Samtsov VS
Probl Tuberk; 1991; (3):34-6. PubMed ID: 1871090
[TBL] [Abstract][Full Text] [Related]
8. [Short term treatment of infantile pulmonary tuberculosis].
Garciá López JR; Vidal López ML; Castán Vidal ML; Borque Andrés C; de José Gómez MI; García Hortelano J
An Esp Pediatr; 1989 Aug; 31(2):110-3. PubMed ID: 2696390
[TBL] [Abstract][Full Text] [Related]
9. Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment.
Khadka P; Dummer J; Hill PC; Das SC
Int J Pharm; 2018 Sep; 548(1):244-254. PubMed ID: 29983396
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
